Traditional risk factors of CVD are well defined: diabetes, hypertension, dyslipidemia, family history of heart dis- ease, smoking, physical inactivity, poor diet, and obesity. Clinical risk stratification tools and risk scores have been developed for stratifying risk and tailoring preventive interventio...
Introduction: the novelty introduced by the latest 2013 ACC/AHA guideline on the treatment of blood cholesterolThe new 2013 ACC/AHA Guidelines in hypercholesterolemic adults [1] have spurred major debates in the medical community as well as in the lay press. Compared with the previous report ...
Introduction: the novelty introduced by the latest 2013 ACC/AHA guideline on the treatment of blood cholesterolThe new 2013 ACC/AHA Guidelines in hypercholesterolemic adults [1] have spurred major debates in the medical community as well as in the lay press. Compared with the previous report of...
February 14, 2023 Circulation. 2023;147:e76–e91. DOI: 10.1161/CIR.0000000000001124 Dr Wei is employed by the National Heart, Lung, and Blood Institute. The content of this article is solely the responsibility of the authors and does not necessarily repre- sent the official views of the Nat...
Update on the management of dyslipidemia. The third edition of guidelines from the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Choleste... K Brian,Irons,A Kathleen,... - American journal of health-system pharmacy : AJHP : official jou...
FullText Read More About CardiologyDyslipidemiaCardiovascular Risk FactorsClinical Decision SupportClinical Pharmacy and PharmacologyEndocrinologyGuidelinesDiabetes JAMA+ AI
Background:In the general population, dyslipidemia impacts 36% of adults between the ages of 20 and 29 years. Among survivors of childhood, adolescent, and... M Dean,J Bane,Y Hang,... - 《Circulation》 被引量: 0发表: 2023年 Perioperative Beta Blockade in Noncardiac Surgery: A Systematic...
A recent study reported a high prevalence of non-communicable disease (NCD) risk factors including hypertension, diabetes, dyslipidemia and obesity in the Middle East and North Africa (MENA) countries5. In 2005, high blood pressure was responsible for 80,000 deaths in Iran6. Moreover, we ...
Clinical controversies ignited by these guidelines led to the publication of recommendations by the NLALaura H. WaiteYvonne L. PhanSarah A. SpinlerJournal of the American Pharmacists AssociationWaite LH, Phan YL, Spinler SA. What's next for dyslipidemia management? The 2013 ACC/AHA Guidelines, ...
How effective are the ESC/EAS and 2013 ACC/ AHA guidelines in treating dyslipidemia? Lessons from a lipid clinic. Curr Med Res Opin. 2015; 31: 221-228.Barkas F, Milionis H, Kostapanos MS, Mikhailidis DP, Elisaf M, Liberopoulos E, 2015 How effective are the ESC/EAS and 2013 ACC/...